Summary
Five FDA 510(k) decisions are linked to selected current families: DISKOM (K180315; March 26, 2018), Renova Spine Balloon Catheter (K231340; October 30, 2023), bone marrow aspiration kits (K203397; January 11, 2021), and biopsy needles (K130616 and K010735). DISKOM’s cleared use covers aspiration of disc material during lumbar, thoracic and cervical percutaneous discectomies. [20][21][22][23]
K203397 covers bone marrow aspiration/explant through a piston syringe; it does not establish approval of a stem-cell therapy. Current-model U.S. authorization for adipose-processing, fertility, aesthetic and airway products has not been established. Two 2001 decisions, EASYBELL (K011075) and OSTEOBELL (K011104), are retained as unresolved historical mappings and excluded from the current count. [22]
FDA recall event 87696, initiated March 22, 2021, covers specified biopsy, kyphoplasty and cement-delivery products distributed as sterile that may not have been sterilized. The reviewed records contain 19 product recall entries within this single event, all marked terminated on February 17, 2026. These findings do not identify DISKOM as affected. No additional matching event was identified in the searches performed; broader model/OEM coverage remains incomplete. [24][25][26][27]